Provided by Tiger Trade Technology Pte. Ltd.

HeartFlow Inc

50.39
+2.615.46%
Post-market: 50.600.2100+0.42%19:41 EDT
Volume:2.63M
Turnover:131.31M
Market Cap:4.38B
PE:-36.92
High:50.99
Open:47.68
Low:47.13
Close:47.78
52wk High:51.19
52wk Low:20.13
Shares:86.95M
Float Shares:79.99M
Volume Ratio:1.53
T/O Rate:3.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3650
EPS(LYR):-3.1700
ROE:-154.23%
ROA:-18.05%
PB:15.66
PE(LYR):-15.90

Loading ...

CORRECTION: HeartFlow Q2 Adj. EPS $(0.07) Beats $(0.13) Estimate, Sales $53.190M Miss $56.642M Estimate

Benzinga Earnings
·
Aug 14

GUIDANCE: (HTFL) Heartflow Expects 2026 Revenue Range $246M-$250M, vs. FactSet Est of $230.1M

MT Newswires Live
·
Aug 14

Heartflow Inc Q2 Gross Profit USD 53.19 Million

THOMSON REUTERS
·
Aug 14

Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

GlobeNewswire
·
Aug 14

Heartflow CEO John C.M. Farquhar Disposes of 22,562 Common Shares Worth $638,932.22

Reuters
·
Aug 13

Earning Preview: HeartFlow Inc revenue is expected to increase by 31.42%, and institutional views are bullish

Earnings Agent
·
Aug 06

Baird Initiates HeartFlow at Outperform With $34 Price Target

MT Newswires Live
·
Jul 31

Heartflow to Report Q2 2026 Results After Market Close, Host Conference Call

Reuters
·
Jul 24

Heartflow Chief Medical Officer Campbell Rogers Disposes of 9,219 Common Shares Worth $237,077.68

Reuters
·
Jul 18

Heartflow CEO John C.M. Farquhar Disposes of 22,562 Shares Worth $626,095.5

Reuters
·
Jul 14

Brandon Vazquez Reiterates Buy on HeartFlow, Citing Strengthening Product Portfolio, Clinical Validation, and Long-Term Growth Potential

TIPRANKS
·
Jul 13

Heartflow Says New Press Release is Available on SCCT 2026 Plaque Analysis Data

Reuters
·
Jul 09

Heartflow Initiated at Buy by Freedom Capital Markets

Dow Jones
·
Jul 01

HeartFlow, Inc. (HTFL) Receives a New Rating from Freedom Capital Markets

TIPRANKS
·
Jul 01

Heartflow initiated with a Buy at Freedom Capital

TIPRANKS
·
Jul 01

Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 30

Heartflow CEO John C.M. Farquhar Disposes of 38,900 Common Shares for $1.36 Million

Reuters
·
Jun 27

HeartFlow Shareholders Reelect Directors, Ratify PwC Auditor

TIPRANKS
·
Jun 19

Heartflow shareholders approve PwC as auditor for fiscal 2026

Reuters
·
Jun 19

Heartflow CEO John C.M. Farquhar disposes of 22,562 common shares worth $642,017

Reuters
·
Jun 13